nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2023, 11, v.32 861-864
帕博利株单抗引发心肌炎、肌炎和心律失常1例
基金项目(Foundation):
邮箱(Email): zrf61520@163.com;
DOI: 10.19577/j.1007-4406.2023.11.011
发布时间: 2023-11-25
出版时间: 2023-11-25
移动端阅读
摘要:

报道1例由帕博利珠单抗引发的重症心肌炎合并肌炎及恶性心律失常的病例。患者,男性,78岁,因“发作性胸闷3 d”于2022年8月21日入院。入院后完善相关检查,并积极对症支持治疗,临床药师结合患者PD-1抑制剂用药史及检查结果,考虑患者“药物性心肌炎:ICI相关性心肌炎可能性大”,予大剂量甲泼尼龙(1 g·d-1)静脉冲击治疗。经治疗,患者病情好转。

Abstract:

KeyWords:
参考文献

[1]史佳宇,牛婧雯,沈东超,等.免疫检查点抑制剂相关神经系统不良反应的临床诊治建议[J].中国肺癌杂志, 2019, 22(10):633.

[2] POWER J R, ALEXANDRE J, CHOUDHARY A, et al. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis[J]. Arch Cardiovasc Dis, 2022,115(5):315.

[3]苏毅馨,朱世杰,薛鹏,等.抗PD-1/PD-L1治疗肿瘤的心脏毒性不良事件研究进展[J].现代肿瘤医学, 2020, 28(23):4164.

[4] MARINI A, BERNARDINI A, GIGLI G L, et al. Neurologic adverse events of immune checkpoint inhibitors:a systematic review[J].Neurology, 2021, 96(16):754.

[5]梁瑜,孟真,李祥鹏,等.帕博利珠单抗致免疫相关性肌炎合并心肌炎、肝损伤患者的药物服务[J].医药导报, 2023, 42(4):575

[6] SHAH M, TAYAR J H, ABDEL-WAHAB N, et al. Myositis as an adverse event of immune checkpoint blockade for cancer therapy[J].Semin Arthritis Rheum, 2019, 48(4):736.

[7]陈怡帆,程蕾蕾,葛均波.免疫检查点抑制剂相关心肌炎分子机制研究进展[J].中国临床医学, 2022, 29(2):260.

[8]高继先,刘小熊,夏豪.免疫检查点抑制剂相关心肌炎研究进展[J].疑难病杂志, 2022, 21(12):1311.

[9]中国抗癌协会整合肿瘤心脏病学分会,中华医学会心血管病学分会肿瘤心脏病学学组,中国医师协会心血管内科医师分会肿瘤心脏病学专业委员会,等.免疫检查点抑制剂相关心肌炎监测与管理中国专家共识(2020版)[J].中国肿瘤临床, 2020, 47(20):1027.

[10] TOUAT M, TALMASOV D, RICARD D, et al. Neurological toxicities associated with immune-checkpoint inhibitors[J]. Curr Opin Neurol, 2017, 30(6):659.

[11] MA R L, WANG Q, MENG D Y, et al. Immune checkpoint inhibitors-related myocarditis in patients with cancer:an analysis of international spontaneous reporting systems[J]. BMC Cancer,2021, 21(1):38.

[12]中国医师协会呼吸医师分会,中国医师协会肿瘤多学科诊疗专业委员会.免疫检查点抑制剂相关毒性防治与管理建议[J].中华医学杂志, 2022, 102(24):1811.

[13] HOLSTEAD R, KARTOLO A, BAETZ T. Emergency department utilization for patients receiving immune checkpoint inhibitors:a retrospective analysis of identification and outcomes for those presenting for immune-related adverse events[J]. Curr Oncol,2020, 28(1):52.

[14] YEUNG S J, QDAISAT A, CHAFTARI P, et al. Diagnosis and management of immune-related advers e effects o f immune checkpoint therapy in the emergency department[J]. J Am Coll Emerg Physicians Open, 2020, 1(6):1637.

基本信息:

DOI:10.19577/j.1007-4406.2023.11.011

中图分类号:R969

引用信息:

[1]张海红,张芙蓉,牛晓霞.帕博利株单抗引发心肌炎、肌炎和心律失常1例[J].中国临床药学杂志,2023,32(11):861-864.DOI:10.19577/j.1007-4406.2023.11.011.

发布时间:

2023-11-25

出版时间:

2023-11-25

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文